Summrar A range of pure. monomeric porphyrins were synthesised and their localising capacities compared to HpD and Hp at 6 h and 24 h post injection in the mouse C6 intracerebral glioma model as well as in normal brain. skin. muscle, kidney. spleen, liver. lung and whole blood. The partition coefficients were examined between PBS and 2-octanol over the pH range 7.4-6.6 and pH profiles were established. A parabolic relationship was observed between log (porphyrin tumour concentration) at pH 7.4. With maximal tumour localisation at log (partition coefficient). a. of approximately zero. Porphynns with side chains with nett cationic character also exhibited an upward (parabolic) dependence on x for most tissues studied. with maximal porphyrin localisation at iE of 0-0.5. In contrast. those porphyrins with nett anionic character exhibited a downward (negative) parabolic trend for all eight tissues studied. with minimal porphyrin localisation at x of approximately zero. Four porphyrins (4. 11. 12, 13) exhibited similar or better tumour localisation than HpD. and two (11 and 12) offer promise as lead compounds for the design of improved porphyrins for use in PDT.
Porphynrns are currently used in the photodynamic treatment of tumours (Kaye et al.. 1988) . Haematoporphyrin derivative (HpD) is the most clinically used porphyrin and is the 'benchmark' compound to which all other prospective phototherapeutic compounds are compared. The physicochemical properties of the porphyrin (chemical structure, aggregation states and hydrophobicity) are considered to be determinants of localisation and photodynamic activity (Jori & Reddi. 1990) . However. as a clinical drug HpD has many drawbacks. one of which is skin photosensitisation that persists after treatment. Furthermore, it is a controversial mixture of compounds and the chemical structures responsible for localisation and photodynamic effectiveness have yet to be elucidated (Byrne et al., 1987; Dougherty, 1987; Kessel et al.. 1987) .
Cerebral gliomas are particularly suited to treatment by photodynamic therapy (PDT). The current treatments such as surgery. chemotherapy and radiotherapy are inadequate. with the median survival for high grade glioblastoma multiforme being less than 1 year (Walker et al.. 1980) . Cerebral tumours are responsible for 2% of all cancer deaths (Kaye. 1989). The major reason for the encouraging results of PDT with these tumours is the extent of localisation and retainment of HpD that can be obtained within intracranial tumours. Most treatments fail because of local recurrence of the glioma. whereas PDT is a local treatment which eliminates any such recurrence. Brain tumour to normal brain ratios of HpD have been reported to be as high as 50: 1 (Hill et al., 1990) . whilst animal tumours of the colon and pancreas that have been treated with aluminium sulphonated phthalocyanine or HpD have ratios of 2-3:1 between tumour and the surrounding normal tissue (Bown. 1990 ). The selective localisation in glioma is considered to be due to the breakdown of the blood-brain barrier within the tumour region -porphyrin can therefore be taken up by the tumour. but is excluded from normal brain which retains an intact blood-brain bamrer (Kaye et al., 1985) .
In order to establish basic structure-activity relationships for uptake of porphyrins in glioma. a range of pure monomeric porphyrins were synthesised and the localisation of these porphyrins was studied in the mouse C6 intracerebral glioma model of Kaye et al. (1986 Tissue extraction procedure The porphyrin content of the tissues was determined using the method of Kessel and Cheng (1985) Mel- bourne, Australia). Triplicate 2 ml aliquots were removed, and each was then extracted into 5 ml chloroform-methanol (1:1. v v), thoroughly vortexed and centrifuged for 5 min at 2.000 g at room temperature in a bench centrifuge (Clements GS200, Selby Scientific, Melbourne, Australia). The upper phase and cell debris layer were discarded. The lower organic phase was then evaporated under a stream of N2 gas. The dried residue was then suspended in 2 ml of buffer (50 mm HEPES, 10 mM CTAB, pH 7.4) and vortexed. This procedure was followed for porphyrins 2-13. HpD (1) underwent a hydrolysis step (Hill et al., 1990) to convert some poorly fluorescing components of HpD to haematoporphyrin plus hydroxyethylvinyldeuteroporphyrin, which exhibit enhanced fluorescent yields (Kessel & Cheng, 1985) . The HpD samples were thus heated in sealed tubes in 0.5 mM HCI at 100°C for 30 min and then neutralised with 1 M NaOH. The absorbance of all porphyrin solutions was determined prior to fluorescence measurements. Absorbance was determined at 400 nm using a Beckman DU-65 spectrophotometer (Beckman Instruments Pty. Ltd., Melbourne, Australia) relative to a control blank. The absorbance readings were necessary since dilutions were sometimes required to prevent concentration-dependent quenching of subsequent fluorescence emission measurements. The porphyrin solution was diluted appropriately (Hill et al., 1990) if the absorbance in a 1 cm path length cell was greater than 0.15.
The fluorescence of the samples were determined using a Perkin-Elmer LS-30 spectrofluorimeter (Perkin-Elmer Pty. Ltd., Melbourne, Australia). The excitation and emission wavelengths were established for each porphyrin. The total porphyrin content in each sample was determined relative to a standard curve of known porphyrin amounts prepared by the same procedure. The assay was highly reproducible with errors of less than 5% and resulted in >95% extraction of HpD from the various tissues (Hill et al.. 1990 
Results

Biodistribution of porphkrin analogues
The structures of the porphyrins studied are presented in Figure 1 . The porphyrins vary in structure. ranging from tetra-anionic pendant side chains through to tetracationic side chains. The distribution of porphyrins in mouse tissues and blood is shown in Table I Figure 2b . Tumour localisation Figure 3 shows the relationship between partition coefficient and porphyrin tumour localisation at 24 h. HpD (1) and Hp (2) have also been included in this plot even though HpD comprises a mixture of porphyrins (Byrne et al.. 1987 : Dougherty, 1987 Kessel et al., 1987) while Hp may also be impure due to the presence of the secondary alcohol group resulting in possible dehydration products. The data has been plotted as log (tumour concentration) against log (partition coefficient) (designated by x, Martin, 1981) and reveals a general parabolic relationship, with maximal tumour localisation at ix of approxiimately zero (Figure 3) . The Relationship of tissue distribution writh partition coefficient at pH 7.4 for porphvrins wvith cationic side chains The dependence of tissue distribution for the catiomnc porphvnrns at 24 h post injection is shown in Figure 4 with respect to x where the data was plotted as log (concentration in each tissue) *s it. Normal brain was not considered as the blood-brain bamrer is essentially impermeable to all porphvrins. No correlation was apparent for skin. muscle and kidnev distributions at pH 7.4. Parabolic trends were observed with all other tissue samples (tumour. spleen. liver. lung and blood) with maximal tissue localisation at x in the range 0-0.5 in all cases. The correlation coefficients for these parabolic relationships were >0.8 except for blood (0.77).
Relationship of tissue distribution writh partition coefficient at pH 7 4 for porphv rins wt-ith anionic side chains The localisation of anionic porphyrins exhibited a parabolic dependence of tissue concentration with for all tissues ( Figure 5 ). The unexpected feature was that in all tissues this trend was that of a 'negative' parabola with minimal localisation at xi of approximately zero. This is in direct contrast to the cationic porphvrins where a parabolic correlation was observed. with maximal localisation at it of zero. The correlation was significant for tissues (correlation coefficient >0.8) and all tissues exhibited a correlation coefficient >0.7 except skin (0.64). These correlations should still be treated with some caution since thev are based on a limited data set. Furthermore, the data set includes HpD ( =-0.4) which is not a pure species.
Discussion
The time points of 6 and 24 h post injection were chosen for tissue localisation studies since Kaye et al. (1985) showed that maximal uptake in tumour compared to normal brain occurred between 6 and 24 h after i.v. administration of HpD. The porphyrins selected for this study were pure. monomeric compounds as compared to the clinically used porphyrin mixture, HpD. and were synthesised as part of our attempt to establish guidelines for the development of new localisers and photosensitisers for PDT.
Other tissue localisation studies with HpD The tissue distribution of HpD has been reported by many groups in the past and has been reviewed by Henderson and Bellnier (1989) . For comparison to the present work, the most relevant study was by Gomer and Dougherty (1979) . where the distribution was reported for a range of tissues after i.p. injection of tritiated HpD in mice at a dose of 
Reticuloendothelial localisation
The tissues such as the kidney. spleen and liver exhibited higher concentrations than the tumour showing that the porphyrins are not exclusively retained by tumour tissue. Liver, spleen and kidney have shown generally high levels of porphyrins in this study and are part of the reticuloendothelial system and or function as transport systems for serum proteins. Kessel (1986) reported that the distribution of porphyrins is directly associated with the number of LDL receptors in those tissues (liver > kidney> lung > spleen) and this was partially supported by the present results: liver levels were greater than kidney concentrations for 12 of the 13 porphyrins; kidney> lung for nine of the 13: lung> spleen for five of the 13. Tumour cells have an elevated number of low density lipoprotein receptors (Maziere et al.. 1990) pared to similar anionic porphyrins (Woodburn et al., 1991) . Both of these porphyrins therefore possess the desired dual characteristics of exhibiting good tumour localisation and targeting crucial subcellular organelles, and therefore offer good prospects as lead compounds for evaluation of other monomeric porphyrins for use in PDT.
With respect to the localising ability of other porphyrins, the tumour:skin ratio of 20:1 for uroporphyrin I suggests that this compound may be a good candidate for PDT when compared to a ratio of 2.5:1 (El-Far & Pimstone, 1986) and 1.5:1 (Table I) for HpD. However, uroporphyrin I was found to be a poor photosensitiser both in vitro and in vivo (Nelson et al., 1990) . Good tumour localisation was exhibited by 11 and 12 with tumour:skin ratios of 7.2:1 and 2.5:1 respectively and these porphyrins should therefore be tested for PDT activity in vivo.
The reasons, or any theories, regarding the mechanism of uptake of these porphyrins into the various tissues studied cannot, as yet, be proposed since more extensive phamarcological data needs to be acquired. Since the effectiveness of any photosensitiser depends on its circulation and distribution properties, the interaction of the photosensitiser with serum proteins (and in particular lipoproteins) should be considered. The distribution of porphyrins among proteins is generally thought to be dependent on chemical structure (Jori, 1989) and it is for this reason that the tissue distributions of porphyrins is expected to be dependent upon their hydrophobicity, and hence upon their partition coefficient.
Photosensitisers which exhibited an increase of lipophilicity with decreasing pH have been shown to be retained more in tumour tissue than those compounds which exhibit a different trend , and this is consistent with the tissue distributions observed in the present study ( Figure  2a ). HpD (1) and porphyrin 11 had significant concentration levels in tumour and their pH profiles showed an increasing lipophilicity with decreasing pH. Porphyrin 8 had negligible concentration levels in tumour and exhibited a decrease in lipophilicity with decreasing pH. The acidity of tumour tissue (Thistlethewaite et al., 1985) is thought to render membranes more porphyrin soluble (Thomas & Girotti, 1989 and Pottier, 1990) Effect of subcellular localisation The in vitro subcellular localisation sites of porphyrins 1-13 have previously been studied using confocal laser scanning microscopy (Woodburn et al., 1991 2
